GOLDMAN SACHS GROUP INC - KEMPHARM INC ownership

KEMPHARM INC's ticker is KMPH and the CUSIP is 488445206. A total of 70 filers reported holding KEMPHARM INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$146,364
-21.6%
30,366
-17.1%
0.00%
Q2 2023$186,777
+3.4%
36,623
+11.6%
0.00%
Q1 2023$180,571
+68.7%
32,831
+40.8%
0.00%
Q4 2022$107,057
-35.1%
23,324
-11.7%
0.00%
Q3 2022$165,000
-52.0%
26,413
-65.8%
0.00%
Q2 2022$344,000
-55.1%
77,140
-49.3%
0.00%
Q1 2022$766,000
-53.9%
152,158
-20.2%
0.00%
Q4 2021$1,662,000
+5.6%
190,790
+13.1%
0.00%
Q3 2021$1,574,000
+404.5%
168,689
+397.5%
0.00%
Q1 2021$312,00033,9070.00%
Other shareholders
KEMPHARM INC shareholders Q3 2022
NameSharesValueWeighting ↓
Retirement Planning Co of New England, Inc. 327,583$1,801,7071.09%
Mystic Asset Management, Inc. 177,533$976,4320.54%
GREAT POINT PARTNERS LLC 347,824$1,913,0320.38%
Kovack Advisors, Inc. 122,822$675,5210.09%
City State Bank 14,224$780.04%
Arete Wealth Advisors, LLC 82,290$4530.04%
VisionPoint Advisory Group, LLC 10,217$49,8590.02%
Laurion Capital Management LP 571,200$3,141,6000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 95,143$523,2870.01%
Janney Montgomery Scott LLC 528,755$2,9080.01%
View complete list of KEMPHARM INC shareholders